Sangmi Oh

1.2k total citations
42 papers, 868 citations indexed

About

Sangmi Oh is a scholar working on Molecular Biology, Organic Chemistry and Infectious Diseases. According to data from OpenAlex, Sangmi Oh has authored 42 papers receiving a total of 868 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 13 papers in Organic Chemistry and 9 papers in Infectious Diseases. Recurrent topics in Sangmi Oh's work include Tuberculosis Research and Epidemiology (8 papers), Biochemical and Molecular Research (6 papers) and Mycobacterium research and diagnosis (5 papers). Sangmi Oh is often cited by papers focused on Tuberculosis Research and Epidemiology (8 papers), Biochemical and Molecular Research (6 papers) and Mycobacterium research and diagnosis (5 papers). Sangmi Oh collaborates with scholars based in South Korea, United States and United Kingdom. Sangmi Oh's co-authors include Seung Bum Park, Jongmin Park, Clifton E. Barry, Minho Shong, Helena I. Boshoff, Daniel L. Barber, Shunsuke Sakai, Yeonjin Ko, J. Hun Hah and Myung‐Whun Sung and has published in prestigious journals such as Journal of Biological Chemistry, Angewandte Chemie International Edition and Circulation.

In The Last Decade

Sangmi Oh

39 papers receiving 849 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sangmi Oh South Korea 17 429 397 114 98 97 42 868
Amgad Albohy Egypt 20 471 1.1× 344 0.9× 66 0.6× 46 0.5× 86 0.9× 47 884
Priyadarshini Jaishankar United States 15 522 1.2× 177 0.4× 76 0.7× 75 0.8× 235 2.4× 28 970
Chih‐Shiang Chang Taiwan 18 398 0.9× 269 0.7× 51 0.4× 82 0.8× 57 0.6× 50 853
Arindam Talukdar India 16 406 0.9× 284 0.7× 51 0.4× 57 0.6× 43 0.4× 46 839
Federico Falchi Italy 21 669 1.6× 302 0.8× 105 0.9× 74 0.8× 62 0.6× 47 1.2k
Michael C. Myers United States 17 420 1.0× 443 1.1× 37 0.3× 126 1.3× 44 0.5× 30 991
Paul Hebeisen Switzerland 17 454 1.1× 402 1.0× 158 1.4× 154 1.6× 62 0.6× 39 968
Chunshi Li China 17 302 0.7× 218 0.5× 66 0.6× 31 0.3× 40 0.4× 34 773
Fisayo A. Olotu South Africa 18 439 1.0× 160 0.4× 73 0.6× 144 1.5× 103 1.1× 79 857

Countries citing papers authored by Sangmi Oh

Since Specialization
Citations

This map shows the geographic impact of Sangmi Oh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sangmi Oh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sangmi Oh more than expected).

Fields of papers citing papers by Sangmi Oh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sangmi Oh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sangmi Oh. The network helps show where Sangmi Oh may publish in the future.

Co-authorship network of co-authors of Sangmi Oh

This figure shows the co-authorship network connecting the top 25 collaborators of Sangmi Oh. A scholar is included among the top collaborators of Sangmi Oh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sangmi Oh. Sangmi Oh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Boshoff, Helena I., Neha Malhotra, Clifton E. Barry, & Sangmi Oh. (2024). The Antitubercular Activities of Natural Products with Fused-Nitrogen-Containing Heterocycles. Pharmaceuticals. 17(2). 211–211. 6 indexed citations
2.
Malhotra, Neha, Sangmi Oh, Peter Finin, et al.. (2024). Environmental fungi target thiol homeostasis to compete with Mycobacterium tuberculosis. PLoS Biology. 22(12). e3002852–e3002852. 1 indexed citations
3.
Oh, Sangmi, et al.. (2024). Testing an Innovative Approach to Improve Hypertension Management at a Federally Qualified Health Center. Journal of Public Health Management and Practice. 30. S46–S51.
4.
Boshoff, Helena I., et al.. (2023). Synthesis and Structure–Activity Relationships of a New Class of Oxadiazoles Targeting DprE1 as Antitubercular Agents. ACS Medicinal Chemistry Letters. 14(9). 1275–1283. 4 indexed citations
5.
Oh, Sangmi, M. Daben J. Libardo, Shaik Azeeza, et al.. (2021). Structure–Activity Relationships of Pyrazolo[1,5-a]pyrimidin-7(4H)-ones as Antitubercular Agents. ACS Infectious Diseases. 7(2). 479–492. 13 indexed citations
6.
Ruf, Benjamin, Simon Wabitsch, Chi Ma, et al.. (2021). Activating Mucosal-Associated Invariant T Cells Induces a Broad Antitumor Response. Cancer Immunology Research. 9(9). 1024–1034. 39 indexed citations
7.
Libardo, M. Daben J., Caroline J. Duncombe, Simon R. Green, et al.. (2021). Resistance of Mycobacterium tuberculosis to indole 4-carboxamides occurs through alterations in drug metabolism and tryptophan biosynthesis. Cell chemical biology. 28(8). 1180–1191.e20. 9 indexed citations
8.
Oh, Sangmi, et al.. (2021). Tuberculosis Drug Discovery: A Decade of Hit Assessment for Defined Targets. Frontiers in Cellular and Infection Microbiology. 11. 611304–611304. 42 indexed citations
9.
Kuo, Tony, et al.. (2021). Comprehensive Medication Management as a Standard of Practice for Managing Uncontrolled Blood Pressure. Frontiers in Medicine. 8. 3 indexed citations
10.
Sakai, Shunsuke, Keith D. Kauffman, Sangmi Oh, et al.. (2020). MAIT cell-directed therapy of Mycobacterium tuberculosis infection. Mucosal Immunology. 14(1). 199–208. 54 indexed citations
11.
Oh, Sangmi, et al.. (2019). Stereoselective synthesis of trans-(2R,3S)- and cis-(2R,3R)-disubstituted pyrrolidines. Bulletin of the Korean Chemical Society. 22(3). 327–329.
12.
Kolbe, Katharina, et al.. (2018). Role of Chemical Biology in Tuberculosis Drug Discovery and Diagnosis. ACS Infectious Diseases. 4(4). 458–466. 12 indexed citations
13.
Oh, Sangmi, Yumi Park, Curtis A. Engelhart, et al.. (2018). Discovery and Structure–Activity-Relationship Study of N-Alkyl-5-hydroxypyrimidinone Carboxamides as Novel Antitubercular Agents Targeting Decaprenylphosphoryl-β-d-ribose 2′-Oxidase. Journal of Medicinal Chemistry. 61(22). 9952–9965. 29 indexed citations
14.
Oh, Sangmi, Jaewon Yang, Eunji Jo, et al.. (2016). Benzothiazepinecarboxamides: Novel hepatitis C virus inhibitors that interfere with viral entry and the generation of infectious virions. Antiviral Research. 129. 39–46. 9 indexed citations
15.
Koo, Ja Young, Sangmi Oh, Minseob Koh, et al.. (2013). Total synthesis of eryvarin H and its derivatives and their biological activity as ERRγ inverse agonist. Organic & Biomolecular Chemistry. 11(35). 5782–5782. 6 indexed citations
16.
Park, Jongmin, Sangmi Oh, & Seung Bum Park. (2012). Discovery and Target Identification of an Antiproliferative Agent in Live Cells Using Fluorescence Difference in Two‐Dimensional Gel Electrophoresis. Angewandte Chemie International Edition. 51(22). 5447–5451. 60 indexed citations
17.
Oh, Sangmi & Seung Bum Park. (2011). A design strategy for drug-like polyheterocycles with privileged substructures for discovery of specific small-molecule modulators. Chemical Communications. 47(48). 12754–12754. 139 indexed citations
18.
Oh, Sangmi, et al.. (2010). Construction of a Polyheterocyclic Benzopyran Library with Diverse Core Skeletons through Diversity-Oriented Synthesis Pathway. Journal of Combinatorial Chemistry. 12(4). 548–558. 48 indexed citations
19.
Kim, Don‐Kyu, Jung Hwan Hwang, Sangmi Oh, et al.. (2009). Transcriptional Corepressor SMILE Recruits SIRT1 to Inhibit Nuclear Receptor Estrogen Receptor-related Receptor γ Transactivation. Journal of Biological Chemistry. 284(42). 28762–28774. 60 indexed citations
20.
Oh, Sangmi, Koon Soon Kim, Young Sun Chung, Minho Shong, & Seung Bum Park. (2009). Anti-obesity Agents: A Focused Review on the Structural Classification of Therapeutic Entities. Current Topics in Medicinal Chemistry. 9(6). 466–481. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026